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CASE REPORT
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Abstract
A case of micronodular T-cell/histiocyte-rich B-cell lymphoma of the spleen who had a prior diagnosis of small lymphocytic
lymphoma is presented. Micronodular T-cell/histiocyte-rich B-cell lymphoma of the spleen was ﬁrst described in 2003, and
very few cases have been reported since then. This is the ﬁrst reported case supervening in a patient with pre-existing chronic
lymphocytic lymphoma. We review its clinical, pathologic, and immunohistochemical features and the difﬁculties we
encountered during diagnosis.
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Introduction
A new variant of T-cell/histiocyte-rich large B-cell
lymphoma in the spleen was ﬁrst described by Dogan
et al. in 2003 (1). This new variant was reported to
show a micronodular pattern and no macroscopically
identiﬁable tumor mass in the spleen. Tumor cells
consisted of large, atypical B-cells scattered in T-cell
and histiocyte-rich micronodules. Only a few cases
have been reported since Dogan et al. described this
new lymphoma subtype (2–5). We report here a case
of micronodular T-cell/histiocyte-rich large B-cell
lymphoma of the spleen that was diagnosed with
chronic lymphocytic lymphoma 9 years ago.
Case report
A 57-year-old man was suffering recently from
fatigue, dyspnea, night sweats, and weight loss. He
had a history of chronic lymphocytic leukemia/
small lymphocytic lymphoma and was treated
with cyclophosphamide, vincristine, and prednisone
in 2000. He was in remission for the last 9 years.
Physical examination revealed pallor and splenomeg-
aly. There was no sign of peripheral lymphadeno-
pathy. Routine blood count disclosed pancytopenia.
Abdominal ultrasonography revealed splenomegaly.
Computed tomography conﬁrmed that splenomegaly
was isolated and there was no accompanying lymph-
adenopathy. Clinical diagnosis was relapse of small
lymphocytic lymphoma. A bone-marrow biopsy was
performed for pathologic examination. Histological
examination of the trephine biopsy showed lymphoid
aggregates with an intertrabecular pattern. There
were a few large lymphocytes with vesicular nuclei.
Immunohistochemical study revealed that 90%
of the lymphoid cells were CD3 (+) small T-cells
and approximately 10% of the population was
CD20(+) B-cells (Figure 1). There was no reactivity
with bcl-1, bcl-2, CD5, CD23, and CD10 anti-
bodies. These histological data, especially predomi-
nance of T-cells, suggested that the inﬁltration was
reactive and was not consistent with a relapse of
patient’s previous small lymphocytic lymphoma.
Following bone-marrow examination, a diagnostic
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The spleen measured 36 cm  21 cm  13 cm. The
cut surfaceshowed white nodules with diameters from
1 to 3 mm within the normal-appearing red pulp.
Microscopic examination showed that these nodules
consisted of small to medium-sized lymphocytes and
histiocytes. Most of the nodules also contained scat-
teredlargelymphoidcellswithlargevesicularnucleiand
two to three nucleoli. These micronodules replaced all
white pulp, and there was no remaining uninvolved
white pulp (Figure 2). Immunohistochemical study
showed that small cells accounting for 90%–95% of
the nodules were CD3(+) T-cells (Figure 3). Scattered
large centroblastic cells were positive for CD20, bcl-6,
and CD79a (Figure 4) but negative for CD5, bcl-2,
CD10, CD30, CD15, epithelial membrane antigen
(EMA), CD23, bcl-1, and Epstein-Barr virus/latent
membrane proteins. Ki-67 proliferation index for
centroblastic cells was around 90%.
Discussion
Micronodular T-cell/histiocyte-rich B-cell lymphoma
of the spleen was ﬁrst reported and described by
Dogan et al. in 2003 (1). A few more cases with
the same features have been reported since then (2–
5). All the reported cases of micronodular T-cell/
histiocyte-rich B-cell lymphoma of the spleen pre-
sented with splenomegaly, anemia, and B symptoms.
There was no or minimal lymphadenopathy, which
was usually limited to hilar lymph nodes of the spleen.
Micronodular T-cell/histiocyte-rich B-cell lym-
phoma of the spleen involves white pulp in a
Figure 1. Mostof the cells in the lymphoid aggregateswereCD3(+)
small T-lymphocytes (trephine biopsy, CD3 antibody, counter-
stained with hematoxylin, 400).
Figure 2. White pulp was replaced by micronodular lymphoid
aggregates in the spleen (hematoxylin-eosin, 40).
Figure 3. A total of 90%–95% of the cells in the micronodules were
CD3(+) small T-cells (spleen, CD3 antibody, counterstained with
hematoxylin, 40).
Figure 4. Scattered large centroblastic cells in the micronodules
were CD20(+) B-cells (spleen, CD20 antibody, counterstained
with hematoxylin, 400).
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tered large cells in a background of CD3(+) T-cells
and CD68(+) histiocytes. The large tumor cells
express B-cell markers CD20 and bcl-6. They are
variably positive for EMA, bcl-2, and CD30 and
negative for CD10 and Epstein-Barr virus/latent
membrane proteins. Since no follicular dendritic
cell mesh-work can be demonstrated by CD21,
Dogan et al. advised this variant of lymphoma to be
classiﬁed and managed as a variant of diffuse large
B-cell lymphoma (1).
All morphological and immunohistochemical fea-
tures in our patient are consistent with the diagnosis
of micronodular T-cell/histiocyte-rich B-cell lym-
phoma of the spleen.
Dogan et al. reported that diagnosis of micronod-
ular T-cell/histiocyte-rich B-cell lymphoma of the
spleen was very difﬁcult if the marrow biopsy was
examined without the knowledge of the splenic his-
tology, as was the case for our patient (1). They
informed that features in bone-marrow might suggest
follicular lymphoma, B-chronic lymphocytic leuke-
mia, mantle cell lymphoma, classical Hodgkin’s lym-
phoma, nodular lymphocyte predominant Hodgkin’s
lymphoma, T-cell lymphoma, and reactive changes,
and a precise diagnosis might be very difﬁcult without
a splenectomy. Our patient’s history of small lympho-
cytic lymphoma further complicated an accurate diag-
nosis. Bone-marrow biopsy revealed a T-cell-rich
inﬁltrate, and there were no histologic ﬁndings con-
sistent with small lymphocytic lymphoma. Prior his-
tory of small lymphocytic lymphoma in our case led us
to a probable diagnosis of reactive changes in bone-
marrow biopsy and a splenectomy was needed for
accurate diagnosis.
Apart from Wang et al., no reported cases were
associated with a different lymphoma type. Wang
et al. reported co-occurrence of splenic marginal
zone lymphoma and micronodular T-cell/histiocyte-
rich large B-cell lymphoma in the spleen. Similar to
other indolent lymphoid neoplasms, splenic marginal
zone lymphoma may undergo transformation to large
B-cell lymphoma (6). Wang et al. speculated that their
case could be a splenic marginal zone lymphoma
undergoing transformation to micronodular T-cell/
histiocyte-rich B-cell lymphoma of the spleen (4).
Our patient had a history of small lymphocytic
lymphoma. Small lymphocytic lymphoma/chronic
lymphocytic leukemia is characterized by a variable
clinical course. A subset of patients has indolent
disease for decades, whereas others develop a second-
ary aggressive lymphoma, mostly diffuse large B-cell
lymphoma. This event has been termed Richter’s
transformation (7). The interval between the initial
diagnosis and Richter’s transformation ranges from
0 to 10 years (8). Micronodular T-cell/histiocyte-
rich B-cell lymphoma of the spleen is an aggressive
neoplasm and was advised to be managed as a
variant of diffuse large B-cell lymphoma (1). Micro-
nodular T-cell/histiocyte-rich B-cell lymphoma of
the spleen in our case seems to represent a Richter’s
syndrome.
Diagnosis of micronodular T-cell/histiocyte-rich
B-cell lymphoma of the spleen in a bone-marrow
biopsy could be very difﬁcult. Follicular lymphoma,
B-chronic lymphocytic leukemia, mantle cell lym-
phoma, Hodgkin’s lymphoma, T-cell lymphomas,
and especially reactive changes should be counted
as differential diagnoses. It is an aggressive neoplasm
and can be transformed from an indolent lymphoma.
Additional reports and studies are needed to establish
features of this rare B-cell lymphoma variant.
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